FOUNDED IN 1996

OUR RESEARCHPUBLICATIONS

UNIQUE EXPERTISE

Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.

UNIQUE CAPABILITIES

We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.

UNRIVALED CAPABILITIES

OUR PUBLICATIONS

We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.

SELECTED PUBLICATIONS

NEWS

Rounding off the human genome

Rounding off the human genome

In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits.

Monozygous but not identical

Monozygous but not identical

By sequencing the germline genomes of twins and comparing them to those of close relatives, scientists at deCODE genetics found mutations that are present in just one of the monozygotic twins and traced them back to the first days after conception.

Award by the American Society of Human Genetics

At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.